The Regulatory Effect of Firm Size on Digital Transformation: An Empirical Study of Pharmaceutical Companies in China
Table 9
Summary of research hypotheses.
Hypothesis
Validation results
H1: The external environment can have a significant influence on the DT of pharmaceutical companies
Supported
H1a: Customer needs can have a significant influence on the DT of pharmaceutical companies
Supported
H1b: Market competition can have a significant influence on the DT of pharmaceutical companies
Supported
H1c: Government policy can have a significant influence on the DT of pharmaceutical companies
Supported
H1d: Digital technology can have a significant influence on the DT of pharmaceutical companies
Supported
H2: The internal conditions can have a significant influence on the DT of pharmaceutical companies
Supported
H2a: Digital strategy can have a significant influence on the DT of pharmaceutical companies
Supported
H2b: Organization capability can have a significant influence on the DT of pharmaceutical companies
Supported
H2c: Leadership can have a significant influence on the DT of pharmaceutical companies
Supported
H3: Firm size can have a significantly regulatory influence on the relationship between the external environment and the DT of pharmaceutical companies
Supported
H4: Firm size can have a significantly regulatory influence on the relationship between the internal conditions and the DT of pharmaceutical companies
